Boston-based Dana-Farber Cancer Institute has launched the Center for RAS Therapeutics, aiming to study and develop drug therapies for RAS-driven cancers.

Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...

Discover Trametinib as a promising treatment for severe hypertrophic cardiomyopathy in children with RASopathies.

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. The ...

After the 2024 election, political attention turns to governor races in Virginia and New Jersey as well as special election ...

Other approaches that are in development include fibroblast growth factor (FGF) mimetics such as FGF21-targeting candidates ...

Results of genetic testing will become an integral part of the premarital screening program starting January 2025 and will be declared in 14 days, Emirates..

Historically, scientists in the division were the first to make the ground-breaking discovery of the mechanism by which the RAS gene – one of the most commonly activated genes in cancer – causes cells ...

The genetic testing list includes 570 genes that cover over 840 medical conditions ... at the Al Khazan and Falaj Al Mualla centres. In Ras Al Khaimah, services will be provided at the Ras Al ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Rather, they ended up with it through a computational analysis of previously published gene expression profiles ... shorthand for Ras-related C3 botulinum toxin substrate 1.